Introduction
variety of quinone compounds, which prevents the generation of free radicals and ROS, and protects cells from oxidative damage.
Some evidence suggests that NQO1 may also interact directly with ROS, such as hydroxyl radical and hydrogen peroxide, which may influence the oxidant-antioxidant balance [8, 9] . NQO1 expression is induced by oxidant stress, aromatic hydrocarbons, phenols, and certain industrial acrylates and metals [7] . Though NQO1 reduces quinones to hydroquinones, not all of these products are redoxstable. In some cases, metabolism by NQO1 results in a more active product where redox-labile hydroquinones can react with molecular oxygen (perhaps in cases of hyperoxia) to form semiquinones. These semiquinones in turn can result in the generation of ROS and cause alkylation of DNA [7] .
A number of single nucleotide polymorphisms (SNPs) have been identified in NQO1. Only two of these, Arg139Trp and Pro187Ser [10, 11] , have been studied extensively and are implicated in risk of a variety of cancers. NQO1 is highly inducible [12] [13] [14] [15] , but little is known about function of promoter SNPs. The role of NQO1 in ALI has not been investigated, but the effects of modulation of NQO1 activity in preliminary studies suggest that alterations in its function could enhance lung injury. Because ALI has been associated with oxidant stress, and a number of investigations have found an association between oxidant stress and NQO1 [13, 16, 17] Fig. 1 ; Table 1 ). SNPs chosen for investigation were within 2 kb of the 5' end and had a minor allele frequency of Ͼ5%. Other NQO1 promoter polymorphisms have been identified (rs2965757, rs689459, rs689458, rs689457, rs12922457) but they were not investigated because they have allele frequencies Ͻ5% which limited power to determine their importance in our study population. Primers (Sigma Genosys, The Woodlands, TX, USA) were then designed to amplify the region of interest for the purpose of genotyping genomic DNA from our cohort to identify the presence of polymorphisms ( Table 2) .
Methods

Selection of SNPs
NQO1 promoter SNPs were identified through a search of Medline and the SNP database in the National Library of Medicine (www.ncbi.nlm.nih.gov), and their positions were localized (
Construction of promoter SNPs and transfection into BEAS-2B cells
Promoter SNP constructs were made utilizing a reporter gene assay. To determine the roles of the Ϫ1103, Ϫ1221 and Ϫ1293 SNPs on NQO1 [18] . Two clinicians reviewed all chest radiographs, and when discordant, a third clinician adjudicated. All three were experienced at interpreting chest radiographs for ALI.
Blood samples from these patients were collected at the time of admission to the emergency department. The samples were centrifuged, and genomic DNA was extracted from thawed buffy coat aliquots using the Qiagen Qiamp 96 DNA Blood Kit (Qiagen). Because no sequence data were obtained for subjects due to either poor amplification during PCR (n ϭ 10) or exhaustion of genomic DNA (n ϭ 11), 257 subjects were included in the analysis. 
Sequencing of SNPs in the major trauma cohort
Primers designed to amplify the region of the NQO1 promoter SNPs were used to amplify the region of interest (Table 2). Various sites were amplified
Statistical analysis
In vitro oxidant exposure study. 
Results
Selection of SNPs
Three promoter polymorphisms in NQO1 were selected for investigation (Table 1) NQO1 is an antioxidant enzyme which has a role in regulating the production of ROS [7] . Two characterized polymorphisms in this enzyme have been shown to predict response to treatment in patients with cancer and myeloid leukaemias [10, 11] [24, 25] . The mechanism by which the A-1221C SNP affects the promoter activity of NQO1 is not known. Because NRF2 is important in regulation of NQO1 expression [26] , a bioinformatic analysis [27] [16, 26, 29] , presumably to reduce oxidant injury. However, NQO1 can also be a pro-oxidant under certain conditions [7] 
Transfected cells were also exposed to lipopolysaccharide (LPS) and luciferase activity was significantly increased in the wild-type construct and SNP Ϫ1293A (P Ͻ 0.05; Fig. 2D). A minimal increase in luciferase activity was found in cells with the Ϫ1221C SNP after exposure to LPS, and a significant (P Ͻ 0.001) interaction between exposure and the SNP was found. The SNP Ϫ1103G caused significantly decreased expression of luciferase relative to wild-type cells (P Ͻ 0.05).
Association analysis
The trauma cohort was genotyped for each of the NQO1 promoter SNPs and genotype (Table 4) and allelic (Table 5) frequencies were calculated. HWE was calculated for each of the selected SNPs. The A-1221C SNP conformed to HWE predictions, whereas the G-1293A and A-1103G did not (results not shown). Allele frequencies for the trauma cohort did not differ from the published allele frequencies for the G-1293A and A-1103G SNPs. Chi-square analysis of the incidence of ALI among homozygous wild-type,
Fig. 2 Luciferase activity of promoter polymorphisms A-1103G, A-1221C and G-1293A after exposure to hyperoxia (A), hydrogen peroxide (H2O2; B), beta-hydroxytoluene (BHT, C) and lipopolysaccharide (LPS, D). Data are presented as means
